ASK PHARM(SZ:002755) Xin Lang Cai Jing·2025-10-15 02:32Core Insights - The stock price of Aosaikang increased by 2.01% on October 15, reaching 19.30 CNY per share, with a total market capitalization of 17.913 billion CNY [1] - Aosaikang's stock has seen a year-to-date increase of 53.30%, but has experienced declines of 6.90% over the last five trading days, 12.75% over the last twenty days, and 10.90% over the last sixty days [1] - The company reported a revenue of 1.007 billion CNY for the first half of 2025, reflecting a year-on-year growth of 9.20%, and a net profit of 160 million CNY, which is a significant increase of 111.64% [2] Company Overview - Aosaikang Pharmaceutical Co., Ltd. was established on December 24, 1996, and went public on May 15, 2015. The company is located in Jiangning Science Park, Nanjing, Jiangsu Province [1] - The main business areas include research, production, and sales of drugs, with revenue composition as follows: oncology drugs 38.28%, anti-infection drugs 24.74%, chronic disease drugs 21.65%, digestive drugs 12.33%, and others 2.34% [1] Shareholder and Dividend Information - As of September 20, 2025, the number of shareholders increased by 2.46% to 20,000, while the average number of circulating shares per person decreased by 2.40% to 46,298 shares [2] - Aosaikang has distributed a total of 721 million CNY in dividends since its A-share listing, with 111 million CNY distributed in the last three years [3] - Notable institutional shareholders include Yongying Medical Innovation Mixed Fund, which is a new shareholder holding 11.686 million shares, and Hong Kong Central Clearing Limited, also a new shareholder with 4.687 million shares [3]